Search

Issue
Title
Authors
Avastin in clinical chemotherapy of malignant tumors
Gorbunova V.A.
Supportive therapy for ovarian cancer
Pokataev I.A., Tyulyandin S.A.
Characteristics of the receptor phenotype of tumor-associated immune cells of the epithelial-mesenchymal microenvironment of ovarian cancer
Zhurman V.N.
Laparoscopic pelvic exenteration for malignant tumors of the female reproductive system: a case series
Lyadov V.K., Nevrov A.S., Garipov M.R., Moskalenko A.N., Simbiryov T.V., Galkin V.N.
Disability-Adjusted Life Year (DALY) assessment and economic damage from premature death of cervical uterine and ovarian cancers in the Tomsk Region
Zhuikova L.D., Ananina O.A., Sirotina A.S., Pikalova L.V., Fokin V.A., Kononova G.A.
The role of bevacizumab in the treatment of patients with ovarian and cervical cancer
Khokhlova S.V.
Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study
Sultanbaev A.V., Menshikov K.V., Musin S.I., Nasretdinov A.F., Fatikhova A.A., Izmailov A.A., Lipatov O.N., Ayupov R.T., Sultanbaeva N.I., Menshikova I.A., Serebrennikov G.A.
Benefits and limitations of breastfeeding for mothers with malignant tumors
Ladodo O.B., Iurova M.V., Khokhlova S.V., Rodionov V.V., Sheshko E.L., Zubkov V.V., Makieva M.I., Chutkova D.A., Akhapkina E.S., Degtyarev D.N.
PARP inhibitors in female reproductive system cancers
Pokataev I.A., Tyulyandin S.A.
Hereditary ovarian cancer
Demidova I.A.
VEGF inhibitors: a new era in the treatment of metastatic ovarian cancer
Pignata S.
Analysis of the survival rate of patients with ovarian cancer of stages I–IV: A retrospective study
Zhurman V.N.
A method of laparoscopic installation of port systems for intra-abdominal chemotherapy in patients with advanced ovarian cancer
Lozovaya V.V., Cherkes L.V., Malikhova O.A., Poddubny B.K.
The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
Demidova I.A.
Bevacizumab in advanced ovarian cancer: when, what for and why?
Tjulandina A.S.
Diagram of differential diagnostics of stages of ovarian cancer
Antoneeva I.I., Abakumova T.V., Gening T.P., Gening S.O.
What are the harms and benefits of using pegylated liposomal doxorubicin in women with recurrent epithelial ovarian cancer, alone or in combination with other drugs? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
The effectiveness of targeted therapy in the treatment of common forms of ovarian cancer
Saevets V.V., Vazhenin A.V., Chernova L.F., Shimotkina I.G., Kurchenkova O.V., Mukhin A.A., Taratonov A.V.
Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]
Yudina E.V.
Recurrent of ovarian cancer with lymph node involvement: surgery or chemotherapy? Retrospective cohort study
Stilidi I.S., Egenov O.A., Nered S.N., Kalinin O.E., Shevchuk A.S., Arkhiri P.P., Suleymanov E.A., Tyulyandina А.S.
Olaparib in the maintenance treatment of platinum-sensitive relapse of BRCA mutant ovarian cancer in routine clinical practice: first results of observational study in Russian patients
Artamonova E.V., Kovalenko E.I., Snegovoy A.V., Aksarin A.A., Anciferova T.A., Belonogov A.V., Bilan E.V., Bilenko S.N., Varvus I.M., Gorkovenko E.A., Enikeev R.F., Ermolaeva A.M., Kramskaya L.V., Kononenko I.B., Pechenyy A.P., Safina S.Z., Chupriyanova T.V., Chuhua G.G., Shemyakina A.I., Shikina E.V.
The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice
Khokhlova S.V.
The role of tamoxifen in the therapy of metastatic ovarian cancer
Davidenko I.S., Kazantseva M.V., Porhanova N.V., Ohanyan M.R.
Immuno-morphological characteristics of bone marrow in patients with ovarian cancer
Kozhonalieva A.M., Chulkova S.V., Stilidi I.S., Artamonova E.V., Poddubnaya I.V., Kolbatskaya O.P., Kupryshina N.A., Egorova A.V., Tupitsyn N.N.
Surgery for early-stage ovarian cancer
Nechushkina V.M., Morkhov K.Y., Abduragimova Z.T., Kuznetsov V.V., Selchuk V.Y., Dmitriev V.N.
Insulin-like growth factors in patients with ovarian tumors (results of own research)
Knyazev R.I., Kuznetsov V.V., Bokin I.I., Barinov V.V., Kushlinskiy N.E., Poddubnaya I.V.
The role of angiogenesis blockers in the treatment of metastatic ovarian cancer
Oganian M.R., Kazantseva M.V., Davidenko I.S., Porhanova N.V.
What is the accuracy of different combinations of ultrasound imaging and blood tests to diagnose ovarian cancer in women before and after the menopause? [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]
Yakushina K.A.
The role of cytoreduction surgery in advanced ovarian cancer (review)
Tandelov R.K., Sel'chuk V.Y., Morkhov K.Y., Nechushkina V.M., Kuznetsov V.V.
BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia)
Khokhlova S.V., Gorbunova V.A., Lyubchenko L.N., Imyanitov E.N.
The role of topotecan in prolongation of platinum-free interval in patients with recurrent ovarian cancer
Moskovskaya E.U., Novikova E.G., Korneeva I.A.
Surgical treatment of recurrent ovarian cancer: A review
Egenov O.A., Stilidi I.S., Tyulyandina A.S.
Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
Khokhlova S.V.
Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer
Knyazev R.I., Poddubnaya I.V., Barinov V.V., Bokin I.I.
Selection of the anti-angiogenesis therapy for the first-line chemotherapy in advanced ovarian cancer
Khokhlova S.V.
Clinical significance of the pathological type of tumor in common forms of ovarian cancer: A retrospective study
Zhurman V.N.
Clinical and prognostic significance of matrix metalloproteinase-7 and vascular endothelium growth factor in patients with ovarian cancer
Knyazev R.I., Poddubnaya I.V., Bokin I.I., Barinov V.V.
The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer
Cherkasova M.V., Khokhlova S.V., Limareva S.V., Bazaeva I.Y., Orel N.F., Gorbunova V.A., Poddubnaya I.V.
1 - 38 of 38 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"